Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 128 results for "biocon under kiran mazumdar shaw"

Kiran Mazumdar seeks 5 year exemption from drug price control
Business Insider India

Biocon chief seeks five-year exemption from price control for ...

Biocon chairperson Kiran Mazumdar-Shaw on Wednesday sought a five-year exemption from drug price control and asked the government to desist from ad hoc measures to help the pharmaceutical sector acquire scale and become competitive in the global ... Financial Express, 4 weeks ago
Kiran Mazumdar seeks 5 year exemption from drug price control Business Insider India, 4 weeks ago

Start-up frenzy reflects a herd-like mentality: Kiran Mazumdar-Shaw

India wasn't ready for a woman brewmaster in the 1970s when Kiran Mazumdar returned from Australia with a degree in brewing. No one was willing to take the risk of hiring a woman, not even United Breweries, where her father, Rasendra Mazumdar, had ...
 Smart Investor2 weeks ago

Kiran Mazumder-Shaw: A journey marked by grit

MYTH BREAKER KIRAN MAZUMDAR-SHAW AND THE STORY OF INDIAN BIOTECH Author: Seema Singh Publisher: HarperCollins Pages: 336 Price: Rs 599 When Unilever bought the Biocon Group [in 1989], it perhaps did not do enough 'due diligence' on the Indian ...
 Business Standard India1 week ago Standing her ground  Business Standard India2 weeks ago

Eight Indians in Asia's most powerful businesswomen list

The Forbes list includes Nita Ambani, Arundhati Bhattacharya, Chanda Kochhar and Kiran Mazumdar-Shaw, among others Mumbai: Power does not flow from executive titles. Nita Ambani would know it best. She's married to the richest Indian who heads the ...
 Livemint.com4 weeks ago Nita Ambani, SBI chief in Forbes power list  Hindu Business Line4 weeks ago India's Nita Ambani,...  Khaleej Times4 weeks ago Nita Ambani named most powerful businesswoman in Asia by Forbes [Mint, New Delhi]  Bloomberg4 weeks ago

Withdrawal of customs duty exemption on life saving drugs faces flak

The withdrawal of customs duty exemption on imports of life-saving drugs came under criticism today with Biocon chief Kiran Mazumdar-Shaw saying levy of any kind of duty for these medicines does not resonate well with Indias affordable healthcare mission.
 Deccan Herald2 months ago Custom Duty Exemption Withdrawal on Life Saving Drugs Face Flak  Outlook2 months ago Cust duty exemption withdrawal on life saving drugs face flak  Business Standard2 months ago More pain for patients: essential drugs removed from customs exemptions  catchnews.com2 months ago
Times of India

Biocon net up 79 percent in fourth quarter

Bengaluru, April 27 Biotech major Biocon Ltd. has posted consolidated net profit of Rs.361 crore for the fourth quarter (January-April) of fiscal 2015-16, registering a whopping 79 percent growth year-on-year (YoY) from Rs.201 crore in the like ...
 ProKerala.com1 week ago Landmark quarter for Biocon, net rises 79%  Hindu Business Line1 week ago Biocon expects more filings this year for biosimilars, drugs  Smart Investor1 week ago Biocon Earmarks Rs 268 Crore for Research After Inking Pact With Mexican Firm  New Indian Express1 week ago
Calcutta Telegraph

Biocon's biosimilars progress

MUMBAI: Analysts gave a thumbs up to Biocon after the company said its copy of biopharmaceutical insulin glargine met the primary targets, which in effect takes the product closer to regulatory filings in the US. With the biosimilar insulin ...
 Economic Times1 week ago Biocon in insulin pact  Calcutta Telegraph1 month ago Biocon to co-develop insulin for US market  ProKerala.com1 month ago

Biocon, Mylan to challenge Delhi HC interim order on breast cancer drug

The order does not have material impact on the company as it was not prevented from selling the product, says Biocon Hyderabad: Biocon Ltd and its partner Mylan NV on Wednesday said they are going to challenge the Delhi high court interim order that ...
 Livemint.com1 week ago

Biocon SA inks pact with PiSA of Mexico

Biocon SA, the wholly-owned subsidiary of Biocon has entered into an agreement with Laboratorios PiSA S.A. de C.V (PiSA) of Mexico for the co-development and commercialisation of generic recombinant human insulin (rh-insulin) for the US market. The ...
 Deccan Herald1 month ago Biocon Enters Into Pact With Lab PiSA To Manufacture Rh-Insulin For US  NDTV1 month ago

In a first, Biocon insulin gets Japan nod

Bio-pharma major Biocon on Monday became the first Indian company to receive regulatory approval for a biosimilar insulin in Japan. This approval will enable the company to export Glargine, a biosimilar insulin in a disposable pen to Japan for ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
Get updated on latest news & your favorite topics right in your inbox!
More     Less